Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188486 · ClinicalTrials.gov registry record · NA
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01188486: Clinical Trial NA study, sponsored by Stanford University.
NCT01188486 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01188486, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative candidates or decline surgery. This study assesses the feasibility of stereotactic body radiation therapy (SBRT) as a tool to produce therapeutically useful computed tomography (CT) scans, using standard water-soluble iodinated compounds as the contrast agents.
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- RADIATION Computed Tomography (CT)
- DEVICE Cyberknife
- DEVICE Trilogy
- DEVICE True Beam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
Why NCT01188486 stopped before completion
NCT01188486 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT01188486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01188486 about?
NCT01188486 is a clinical study titled "Pulmonary Interstitial Lymphography in Early Stage Lung Cancer". The stereotactic body radiation therapy (SBRT) procedure is an emerging alternative to the standard treatment for early stage non-small cell lung cancer (NSCLC), typically lobectomy with lymphadenectomy. This procedure (lobectomy) does not fulfill the medical need as many patients are poor operative...
What is the current status of trial NCT01188486?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT01188486?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Computed Tomography (CT) (RADIATION), Cyberknife (DEVICE), Trilogy (DEVICE), True Beam (DEVICE).
Who is sponsoring clinical trial NCT01188486?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01188486's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia